The pipeline for global health innovations is “more robust than it’s ever been,” according to Niranjan Bose, who is managing director of the health and life sciences strategy at Gates Ventures. This includes innovations in areas such as vaccines, drugs, diagnostics, and tools to measure the performance of health systems.
“Continued investment in getting those pipelines to market is one thing that we should not lose sight on, but the pipeline is one that I'm very optimistic about,” he said, while on stage at Devex’s flagship event in Washington, D.C. “Scaling the fantastic pipeline innovations is truly the challenge we're going to face.”
Gates Ventures is Bill Gates' private office that works to complement the Gates Foundation’s work in global health. One of its key projects is Exemplars in Global Health, which is an international research collaboration that identifies positive health outliers, studies successes, and shares findings.
This story is forDevex Promembers
Unlock this story now with a 15-day free trial of Devex Pro.
With a Devex Pro subscription you'll get access to deeper analysis and exclusive insights from our reporters and analysts.
Start my free trialRequest a group subscription